Search by Drug Name or NDC

    NDC 55111-0586-05 Amlodipine Besylate and Benazepril Hydrochloride 10; 40 mg/1; mg/1 Details

    Amlodipine Besylate and Benazepril Hydrochloride 10; 40 mg/1; mg/1

    Amlodipine Besylate and Benazepril Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr.Reddy's Laboratories Limited. The primary component is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE.

    Product Information

    NDC 55111-0586
    Product ID 55111-586_2b57e667-c854-2ed1-32f9-b06c6fea1930
    Associated GPIs 36991502200160
    GCN Sequence Number 060723
    GCN Sequence Number Description amlodipine besylate/benazepril CAPSULE 10 MG-40MG ORAL
    HIC3 A4K
    HIC3 Description ACE INHIBITOR-CALCIUM CHANNEL BLOCKER COMBINATION
    GCN 26950
    HICL Sequence Number 010041
    HICL Sequence Number Description AMLODIPINE BESYLATE/BENAZEPRIL HCL
    Brand/Generic Generic
    Proprietary Name Amlodipine Besylate and Benazepril Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine Besylate and Benazepril Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 10; 40
    Active Ingredient Units mg/1; mg/1
    Substance Name AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
    Labeler Name Dr.Reddy's Laboratories Limited
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Ch
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090149
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0586-05 (55111058605)

    NDC Package Code 55111-586-05
    Billing NDC 55111058605
    Package 500 CAPSULE in 1 BOTTLE (55111-586-05)
    Marketing Start Date 2011-07-05
    NDC Exclude Flag N
    Pricing Information N/A